Dual platelet antiaggregation therapy after myocardial revascularization surgery.

Rev Assoc Med Bras (1992) 2019 Mar 11;65(3):316-318. Epub 2019 Apr 11.

Department of Atherosclerosis of the Heart Institute of the Hospital das Clínicas of the Faculty of Medicine of the University of São Paulo, São Paulo, Brasil.

Coronary artery bypass graft (CABG) is a consolidated treatment in patients with coronary artery disease (CAD) for both symptom control and improvement of prognosis. The patency of venous grafts is still the most vulnerable point of the surgical treatment since it presents a high prevalence of occlusion both in the immediate postoperative period and in the long-term follow-up. Aspirin plays a well-established role in this setting, and for a long time, clopidogrel use has been restricted to patients allergic to aspirin. Recently, subgroup analyses of studies with different anti-platelet therapies have shown reduced mortality and cardiovascular events in patients on dual anti-platelet antiplatelet therapy (DAPT) undergoing CABG, although such studies have not been designed to evaluate this patient profile. However, there is still an insufficient number of randomized studies using DAPT in this context, resulting in a disagreement between the European and American cardiology societies guidelines regarding their indication and generating doubts in clinical practice.

Download full-text PDF

Source
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S
Publisher Site
http://dx.doi.org/10.1590/1806-9282.65.3.316DOI Listing
March 2019
5 Reads

Publication Analysis

Top Keywords

coronary artery
8
studies dapt
4
postoperative period
4
occlusion postoperative
4
cabg studies
4
randomized studies
4
period long-term
4
reduced mortality
4
follow-up aspirin
4
long-term follow-up
4
number randomized
4
prevalence occlusion
4
dapt context
4
surgical treatment
4
point surgical
4
disagreement european
4
vulnerable point
4
undergoing cabg
4
treatment presents
4
high prevalence
4

References

(Supplied by CrossRef)
Aspirin and mortality from coronary bypass surgery
Mangano DT et al.
N Engl J Med 2002
The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
Herbert JM et al.
Thromb Haemost 1998

2012

2015

Similar Publications